Clinical Trial Update: Semaglutide Therapy for Alcohol Reduction - Tulsa [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing semaglutide for reducing alcohol use in adults with Alcohol Use Disorder in Tulsa, Oklahoma, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Oklahoma State University Center for Health Sciences | Conditions: Alcohol Use Disorder | Phase 2 | Status: COMPLETED